First drugs selected for Medicare drug pricing negotiation: reactions, speculation and comments

The ability for Medicare to negotiate drug prices through enactment of the Inflation Reduction Act is a significant milestone in the US healthcare system and one which has polarized opinion. Proponents believe Medicare drug pricing negotiation to be major step forward in the fight to lower drug prices and make prescription drugs more affordable for beneficiaries. Opponents, some of whom have launched legal action aimed at blocking the drug pricing provisions of the IRA, argue these provisions could make it more difficult for drug manufacturers to recoup their research and development costs, potentially stifling innovation. Last week, CMS unveiled the...